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Using puriﬁed reaction components, a commercial monoclonal
antibody (Ab) speciﬁc to RNase inhibitor (RI) was found to inter-
fere with the activity of RI. Total RNA was mixed with a mono-
clonal Ab speciﬁc to either RI (clone 3F11) or glyceraldehyde-3-
phosphate dehydrogenase (GAPDH), RNase A, RI, or a combination
of the above. Following incubation for 1 h at 22 °C or 37 °C, RNA
integrity of the mixtures was assessed using microﬂuidics-based
Bio-Rad Experion RNA electrophoresis. The addition of Ab 3F11
prevented RI from effectively inhibiting RNase A and therefore
resulted in extensive RNA degradation. The data presented are
associated with the research article entitled “Endogenous RNase
Inhibitor Contributes to Stability of RNA in Crude Cell Lysates:
Applicability to Reverse Transcription Quantitative PCR (RT-qPCR)”
(Wang et al., 2016) [1].
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xperimental
factorsRNA in solution was mixed with puriﬁed components (monoclonal antibodies,
RNase A, human placental RNase inhibitor, dithiothreitol) and subjected to incu-
bation at various temperaturesxperimental
featuresFollowing the incubation, RNA was puriﬁed and its integrity was assessed by Bio-
Rad Experion RNA electrophoresisata source
locationFood and Drug Administration (Silver Spring, Maryland, USA)ata accessibility Data is within this articleD
Value of the data
 Using puriﬁed reaction components, a commercial monoclonal Ab speciﬁc to RI (3F11) was found
to interfere with the activity of RI.
 This monoclonal Ab may be a useful reagent for exploring structure-function relationships of RI
and for probing the interaction between RI and its target RNases.
 In addition, this monoclonal Ab may aid in establishing the role of RI as a determinant of RNA
stability in complex mixtures (such as crude cell lysates).1. Data
Mixtures of puriﬁed components (including total RNA, monoclonal Ab speciﬁc to RI or GAPDH,
RNase A, RI, and dithiothreitol) were subjected to incubation for 1 h at various temperatures (on ice,
22 °C, or 37 °C). Following the incubation, RNA was puriﬁed from the mixtures and subjected to
microﬂuidics-based Bio-Rad Experion RNA electrophoresis. Data shown are virtual gel images and
RNA Quality Indicator (RQI) values generated by the Experion software.
The data presented are associated with the research article entitled "Endogenous RNase Inhibitor
Contributes to Stability of RNA in Crude Cell Lysates: Applicability to RT-qPCR" [1].2. Experimental design, materials and methods
2.1. Assessment of contaminating RNase activity in monoclonal Ab reagents
Total RNA from Vero cells was puriﬁed using the RNeasy kit (Qiagen) and diluted in Cell-Lysis (CL)
Buffer (10 mM Tris–HCl pH 7.4, 0.25% Igepal CA-630, 150 mM NaCl) [2]. RNA (5 mg in 200 mL of CL
Buffer) was mixed with 1 mg (1 mL) of monoclonal Ab speciﬁc to either RI (Origene; TA501875; clone
3F11) or GAPDH (Origene; TA802519; clone 2D9). The mixtures were incubated for 1 h on ice, at 22 °C,
or at 37 °C. Following the incubation, RNA was puriﬁed using the RNeasy Mini kit (Qiagen) according
to the “cleanup” protocol supplied with the kit. RNA was eluted in 30 mL of nuclease-free water and
stored frozen at 80 °C until assessment. Samples (1 mL) were subjected to microﬂuidics-based
Experion RNA StdSens electrophoresis (Bio-Rad). Virtual gel images and RQI values were generated
using the Experion software version 3.2. RQIs can range from 1.0 for degraded RNA to 10.0 for intact
Fig. 1. Contaminating RNase activity in Ab reagents. Puriﬁed total RNA (5 mg in 200 mL of CL Buffer) was mixed with 1 mg of
monoclonal Ab speciﬁc to either RI (Origene; TA501875; clone 3F11) or GAPDH (Origene; TA802519; clone 2D9). The mixtures
were incubated for 1 h on ice, at 22 °C, or at 37 °C. Following incubation, RNA was puriﬁed and subjected to Experion analysis.
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quality for most downstream applications such as RT-qPCR.
Data from this experiment are shown in Fig. 1. The extent of RNase contamination was comparable
between the two Ab reagents; according to information from the supplier, both were puriﬁed from
mouse ascites ﬂuid by afﬁnity chromatography. RNA in control reactions in the absence of Ab (CL
Buffer alone) was intact even after incubation for 1 h at 37 °C (RQI of 9.7), thereby demonstrating that
our CL Buffer components are free of RNase activity.
2.2. Inhibition of RI activity by a monoclonal Ab speciﬁc to RI (3F11)
Puriﬁed total RNA from Vero cells (5 mg in 200 mL of CL Buffer) was mixed with 1 mg (1 mL) of
monoclonal Ab speciﬁc to either RI (Origene; TA501875; clone 3F11) or GAPDH (Origene; TA802519;
clone 2D9), 1 ng (1 mL) of RNase A (Qiagen; 19101; diluted in CL Buffer), 40 units (1 mL) of human
placental RI (hpRI; New England Biolabs; M0307), or a combination of the above; in reactions con-
taining hpRI, its addition preceded the addition of other components. The mixtures were incubated
for 1 h at 22 °C or at 37 °C. Following the incubation, RNA was puriﬁed and subjected to Experion
analysis. Data from this experiment are shown in Fig. 2A. The nuclease activity associated with 1 ng of
RNase A (lane 4) exceeded the contaminating nuclease activity associated with the monoclonal Ab
reagents (lanes 2 and 3). The functionality of hpRI was demonstrated by protection against RNA
degradation mediated by RNase A at 22 °C incubation for 1 h (lane 5); further addition of GAPDH Ab
did not affect RNA stability (lane 6), whereas addition of RI Ab led to substantial RNA degradation
(lane 7). At the more stringent stress condition (37 °C for 1 h), hpRI was not able to protect RNA from
degradation (lanes 10 and 11), likely due to the instability of RI in the absence of reducing agent [3].
Fig. 2. Inhibition of RI activity by a monoclonal Ab speciﬁc to RI (3F11). (A) Puriﬁed total RNA (5 mg in 200 mL of CL Buffer) was
mixed with 1 mg of monoclonal Ab speciﬁc to either RI (Origene; TA501875; clone 3F11) or GAPDH; (Origene; TA802519; clone
2D9), 1 ng of RNase A, 40 units of human placental RI (hpRI), or a combination of the above. The mixtures were incubated for
1 h at 22 °C or at 37 °C. Following incubation, RNAwas puriﬁed and subjected to Experion analysis. An asterisk (n) indicates that
the RNA concentration was too low for calculation of RQI. (B) A similar experiment as shown in (A) was performed using CL
Buffer supplemented with 1 mM dithiothreitol (DTT).
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dithiothreitol (Thermo Scientiﬁc; 20291). RNA degradation mediated by RNase A was prevented by
hpRI at both 22 °C (lane 5) and 37 °C (lane 10). Addition of RI Ab interfered with the function of hpRI
at both 22 °C (lane 7) and 37 °C (lane 12), whereas addition of GAPDH Ab had minimal inﬂuence on
RNA stability (lanes 6 and 11).Acknowledgments
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